Ryan Specialty (NYSE:RYAN) Sets New 52-Week Low on Analyst Downgrade

Key Points

• Shares hit a new 52-week low after Keefe, Bruyette & Woods cut its price target from $49 to $42, with the stock tumbling to as low as $29.91 and trading roughly 11% lower on heavy volume.
• Fundamentals were mixed: Ryan reported Q1 revenue up 15.2% to $795.2M and EPS of $0.47 beat estimates, and the company declared a quarterly dividend of $0.13 ($0.52 annualized).
• Analysts have trimmed targets and the consensus rating is an average of Hold (avg. target ~$47.94), while valuation and leverage concerns persist (trailing P/E ~73.6; debt-to-equity ~2.62), which could constrain near-term upside.

Ryan Specialty Holdings Inc. (NYSE:RYAN - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Friday after Keefe, Bruyette & Woods lowered their price target on the stock from $49.00 to $42.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock. Ryan Specialty traded as low as $29.91 and last traded at $30.3970, with a volume of 549129 shares traded. The stock had previously closed at $34.77.

Several other analysts also recently issued reports on RYAN. Bank of America cut their price objective on Ryan Specialty from $70.00 to $68.00 and set a "buy" rating on the stock in a report on Tuesday, April 14th. The Goldman Sachs Group reissued a "buy" rating and issued a $42.00 target price on shares of Ryan Specialty in a research report on Friday. Wells Fargo & Company restated an "equal weight" rating and set a $31.00 price target (down from $42.00) on shares of Ryan Specialty in a report on Friday. BMO Capital Markets downgraded shares of Ryan Specialty from an "outperform" rating to a "market perform" rating and reduced their price target for the company from $66.00 to $43.00 in a research report on Wednesday, February 25th. Finally, Piper Sandler decreased their price objective on shares of Ryan Specialty from $58.00 to $43.00 and set a "neutral" rating for the company in a research note on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $47.94.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the company's stock in a transaction dated Monday, February 23rd. The shares were bought at an average price of $39.96 per share, for a total transaction of $1,018,980.00. Following the acquisition, the director directly owned 428,295 shares of the company's stock, valued at approximately $17,114,668.20. This trade represents a 6.33% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 52.03% of the stock is owned by corporate insiders.

Key Stories Impacting Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Q1 results beat expectations — Revenue grew 15.2% YoY to $795.2M and EPS of $0.47 topped consensus, showing continued top-line momentum and improved net income. This is the main fundamental positive underpinning the stock. Ryan Specialty Reports First Quarter 2026 Results
• Positive Sentiment: Dividend declared — Company announced a quarterly dividend of $0.13/share (annualized yield ~1.7%), with record/ex-dividend dates in May, which can support shareholder returns and income-focused demand. (Company announcement)
• Neutral Sentiment: Management commentary available — The Q1 earnings call transcript is posted; investors should review management’s remarks on growth drivers, margin outlook and M&A strategy to assess sustainability of the beat. RYAN Q1 2026 Earnings Call Transcript
• Negative Sentiment: Analyst price-target cut — Wells Fargo reaffirmed an “equal weight” stance but cut its price target sharply (from $42 to $31), signaling lower near-term upside and prompting sell-side-led trimming. Benzinga
• Negative Sentiment: Valuation and leverage concerns — The stock trades with a high trailing P/E and the company carries meaningful leverage (debt-to-equity ~2.6), which can amplify investor sensitivity to slower growth or margin pressure and contribute to intraday selling. MarketBeat RYAN profile

Hedge Funds Weigh In On Ryan Specialty

Institutional investors and hedge funds have recently modified their holdings of the stock. Los Angeles Capital Management LLC acquired a new stake in Ryan Specialty during the fourth quarter valued at $25,000. Advisory Services Network LLC acquired a new position in Ryan Specialty in the third quarter worth approximately $28,000. SBI Securities Co. Ltd. raised its position in Ryan Specialty by 6,322.2% during the fourth quarter. SBI Securities Co. Ltd. now owns 578 shares of the company's stock valued at $30,000 after acquiring an additional 569 shares in the last quarter. Fifth Third Bancorp lifted its stake in Ryan Specialty by 65.4% in the third quarter. Fifth Third Bancorp now owns 612 shares of the company's stock valued at $34,000 after acquiring an additional 242 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. grew its position in Ryan Specialty by 83.7% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 599 shares of the company's stock worth $35,000 after acquiring an additional 273 shares in the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Ryan Specialty Trading Down 11.1%

The company has a market cap of $8.17 billion, a price-to-earnings ratio of 73.64, a price-to-earnings-growth ratio of 0.95 and a beta of 0.71. The company's 50 day moving average price is $36.08 and its 200 day moving average price is $46.46. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.04. The business had revenue of $795.23 million during the quarter, compared to analyst estimates of $781.44 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. Ryan Specialty's quarterly revenue was up 15.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.39 EPS. Research analysts anticipate that Ryan Specialty Holdings Inc. will post 2.24 EPS for the current year.

Ryan Specialty Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th will be issued a dividend of $0.13 per share. The ex-dividend date of this dividend is Tuesday, May 12th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.7%. Ryan Specialty's dividend payout ratio is currently 123.81%.

About Ryan Specialty

Ryan Specialty Group, Inc NYSE: RYAN is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients' unique needs.

Ryan Specialty's core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.